secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2024-09-17T23:59:59+00:00
Accession:  0001437749-24-029392
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Reviva awards FY2023 bonuses: CEO $157,500, CFO $95,940, VP $77,376 in options
------------------------------------------------------------------------------

- FY2023 incentive bonuses for named executive officers paid as immediately vested stock options in lieu of cash.
- CEO Laxminarayan Bhat granted 158,451 options at $1.20 per share; bonus value $157,500.
- CFO Narayan Prabhu granted 96,519 options at $1.20 per share; bonus value $95,940.
- VP Seema Bhat granted 77,843 options at $1.20 per share; bonus value $77,376.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924029392/0001437749-24-029392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774924029392/rvph20240917_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-029392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer